Micronutrients and cardiorenal disease: Insights into novel assessments and treatment

Blood Purification

Volumn 31, Issue 1-3, 2011, Pages 177-185

  McCullough, Peter A ^a  

^a Providence Park Heart Institute   (United States)

Author keywords

Acute kidney injury; Cardiorenal syndrome; Cardiovascular disease; Chronic kidney disease; Micronutrient; Nutrition

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; FERROUS ION; FOLIC ACID; NICOTINAMIDE; PANTOTHENIC ACID; PYRIDOXINE; RIBOFLAVIN; SELENIUM; THIAMINE; TRACE ELEMENT; VITAMIN D; ZINC;

ACUTE KIDNEY FAILURE; CARDIOVASCULAR DISEASE; CATALYSIS; CHRONIC KIDNEY FAILURE; CLINICAL ASSESSMENT; CONFERENCE PAPER; DISEASE COURSE; HEART FAILURE; HEART FUNCTION; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR; VITAMIN SUPPLEMENTATION;

CARDIOVASCULAR DISEASES; HUMANS; MICRONUTRIENTS; RENAL INSUFFICIENCY, CHRONIC;

EID: 78651423008     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000321853     Document Type: Conference Paper

References (53)

1. McCullough PA: Why is chronic kidney disease the 'spoiler' for cardiovascular outcomes? J Am Coll Cardiol 2003; 41: 725-728.
2. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, Mc- Cullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW, American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention: Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003; 108: 2154-2169. (Pubitemid 37337595)
3. Ronco C, McCullough P, Anker SD, Anand I, Aspromonte N, Bagshaw SM, Bellomo R, Berl T, Bobek I, Cruz DN, Daliento L, Davenport A, Haapio M, Hillege H, House AA, Katz N, Maisel A, Mankad S, Zanco P, Mebazaa A, Palazzuoli A, Ronco F, Shaw A, Sheinfeld G, Soni S, Vescovo G, Zamperetti N, Ponikowski P, for the Acute Dialysis Quality Initiative (ADQI) consensus group: Cardiorenal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative. Eur Heart J 2010; 31: 703-711.
4. Shah SV: Oxidants and iron in chronic kidney disease. Kidney Int Suppl 2004;S50-S55.
5. Walker BL, Tiong JW, Jefferies WA: Iron metabolism in mammalian cells. Int Rev Cytol 2001; 211: 241-278.
6. Richardson DR, Lane DJ, Becker EM, Huang ML, Whitnall M, Rahmanto YS, Sheftel AD, Ponka P: Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol. Proc Natl Acad Sci USA 2010; 107: 10775-10782.
7. Balla J, Vercellotti GM, Jeney V, Yachie A, Varga Z, Jacob HS, Eaton JW, Balla G: Heme, heme oxygenase, and ferritin: how the vascular endothelium survives (and dies) in an iron-rich environment. Antioxid Redox Signal 2007; 9: 2119-2137.
8. Prakash M, Upadhya S, Prabhu R: Serum non-transferrin bound iron in hemodialysis patients not receiving intravenous iron. Clin Chim Acta 2005; 360: 194-198.
9. Kooistra MP, Kersting S, Gosriwatana I, Lu S, Nijhoff-Schutte J, Hider RC, Marx JJ: Nontransferrin- bound iron in the plasma of haemodialysis patients after intravenous iron saccharate infusion. Eur J Clin Invest 2002; 32(suppl 1):36-41.
10. Parkkinen J, von Bonsdorff L, Peltonen S, Grönhagen-Riska C, Rosenlöf K: Catalytically active iron and bacterial growth in serum of haemodialysis patients after i.v. ironsaccharate administration. Nephrol Dial Transplant 2000; 15: 1827-1834.
11. Driss F, Vrtovsnik F, Katsahian S, Michel C, Baron G, Kolta A, Sedrati N, Mentré F, Mignon F, Cabantchik I, Grandchamp B: Effects of intravenous polymaltose iron on oxidant stress and non-transferrin-bound iron in hemodialysis patients. Nephron Clin Pract 2005; 99:c63-c67.
12. Espósito BP, Breuer W, Slotki I, Cabantchik ZI: Labile iron in parenteral iron formulations and its potential for generating plasma nontransferrin-bound iron in dialysis patients. Eur J Clin Invest 2002; 32(suppl 1):42-49.
13. Sengoelge G, Rainer V, Kletzmayr J, Jansen M, Derfler K, Födinger M, Hörl WH, Sunder- Plassmann G: Dose-dependent effect of parenteral iron therapy on bleomycin-detectable iron in immune apheresis patients. Kidney Int 2004; 66: 295-302.
14. Rooyakkers TM, Stroes ES, Kooistra MP, van Faassen EE, Hider RC, Rabelink TJ, Marx JJ: Ferric saccharate induces oxygen radical stress and endothelial dysfunction in vivo. Eur J Clin Invest 2002; 32(suppl 1):9-16.
15. Lyseng-Williamson KA, Keating GM: Ferric carboxymaltose: a review of its use in irondeficiency anaemia. Drugs 2009; 69: 739-756.
16. Lele S, Shah S, McCullough PA, Rajapurkar M: Serum catalytic iron as a novel biomarker of vascular injury in acute coronary syndromes. EuroIntervention 2009; 5: 336-342.
17. Baliga R, Ueda N, Walker PD, Shah SV: Oxidant mechanisms in toxic acute renal failure. Drug Metab Rev 1999; 31: 971-997.
18. Kell DB: Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Med Genomics 2009; 2: 2.
19. Moussavian MR, Slotta JE, Kollmar O, Menger MD, Gronow G, Schilling MK: Posthypoxic cellular disintegration in glycinepreserved renal tubules is attenuated by hydroxyl radical scavengers and iron chelators. Langenbecks Arch Surg 2008; 393: 303-310.
20. McCullough PA: Contrast-induced acute kidney injury. J Am Coll Cardiol 2008; 51: 1419-1428.
21. Bellomo R, Auriemma S, Fabbri A, D'Onofrio A, Katz N, McCullough PA, Ricci Z, Shaw A, Ronco C: The pathophysiology of cardiac surgery-associated acute kidney injury (CSA-AKI). Int J Artif Organs 2008; 31: 166-178. (Pubitemid 351425014)
22. Elahi MM, Battula NR, Hakim NS, Matata BM: Acute renal failure in patients with ischemic heart disease: causes and novel approaches in breaking the cycle of self-perpetuating insults abrogated by surgery. Int Surg 2005; 90: 202-208.
23. Diez C, Haneya A, Brünger F, Philipp A, Hirt S, Ruppecht L, Kobuch R, Keyser A, Hilker M, Puehler T, Schmid C: Minimized extracorporeal circulation cannot prevent acute kidney injury but attenuates early renal dysfunction after coronary bypass grafting. ASAIO J 2009; 55: 602-607.
24. Ranucci M, Ballotta A, Kunkl A, De Benedetti D, Kandil H, Conti D, Mollichelli N, Bossone E, Mehta RH: Influence of the timing of cardiac catheterization and the amount of contrast media on acute renal failure after cardiac surgery. Am J Cardiol 2008; 101: 1112-1118.
25. McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW: Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 1997; 103: 368-375.
26. Del Duca D, Iqbal S, Rahme E, Goldberg P, de Varennes B: Renal failure after cardiac surgery: timing of cardiac catheterization and other perioperative risk factors. Ann Thorac Surg 2007; 84: 1264-1271.
27. Newsome BB, Warnock DG, McClellan WM, Herzog CA, Kiefe CI, Eggers PW, Allison JJ: Long-term risk of mortality and endstage renal disease among the elderly after small increases in serum creatinine level during hospitalization for acute myocardial infarction. Arch Intern Med 2008; 168: 609-616.
28. Adabag AS, Ishani A, Bloomfield HE, Ngo AK, Wilt TJ: Efficacy of N-acetylcysteine in preventing renal injury after heart surgery: a systematic review of randomized trials. Eur Heart J 2009; 30: 1910-1917.
29. Gonzales DA, Norsworthy KJ, Kern SJ, Banks S, Sieving PC, Star RA, Natanson C, Danner RL: A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity. BMC Med 2007; 5: 32.
30. Brown JR, Block CA, Malenka DJ, O'Connor GT, Schoolwerth AC, Thompson CA: Sodium bicarbonate plus N-acetylcysteine prophylaxis: a meta-analysis. JACC Cardiovasc Interv 2009; 2: 1116-1124.
31. Chinnaiyan KM, Alexander D, McCullough PA: Role of angiotensin II in the evolution of diastolic heart failure. J Clin Hypertens (Greenwich) 2005; 7: 740-747.
32. McCullough PA, Jurkovitz CT, Pergola PE, McGill JB, Brown WW, Collins AJ, Chen SC, Li S, Singh A, Norris KC, Klag MJ, Bakris GL, for the KEEP Investigators: Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP). Arch Intern Med 2007; 167: 1122-1129.
33. Yerkey MW, Kernis SJ, Franklin BA, Sandberg KR, McCullough PA: Renal dysfunction and acceleration of coronary disease. Heart 2004; 90: 961-966.
34. McCullough PA, Li S, Jurkovitz CT, Stevens L, Collins AJ, Chen SC, Norris KC, McFarlane S, Johnson B, Shlipak MG, Obialo CI, Brown WW, Vassalotti J, Whaley-Connell AT, Brenner RM, Bakris GL, KEEP Investigators: Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality. Am Heart J 2008; 156: 277-283.
35. McCullough PA, Sandberg KR, Dumler F, Yanez JE: Determinants of coronary vascular calcification in patients with chronic kidney disease and end-stage renal disease: a systematic review. J Nephrol 2004; 17: 205-215.
36. Tintut Y, Demer LL: Recent advances in multifactorial regulation of vascular calcification. Curr Opin Lipidol 2001; 12: 555-560. (Pubitemid 32980305)
37. McCullough PA, Agrawal V, Danielewicz E, Abela GS: Accelerated atherosclerotic calcification and Mönckeberg's sclerosis: a continuum of advanced vascular pathology in chronic kidney disease. Clin J Am Soc Nephrol 2008; 3: 1585-1598.
38. Bhakta M, Bruce C, Messika-Zeitoun D, Bielak L, Sheedy PF, Peyser P, Sarano M: Oral calcium supplements do not affect the progression of aortic valve calcification or coronary artery calcification. J Am Board Fam Med 2009; 22: 610-616.
39. Byrne FN, Kinsella S, Murnaghan DJ, Kiely M, Eustace JA: Lack of correlation between calcium intake and serum calcium levels in stable haemodialysis subjects. Nephron Clin Pract 2009; 113:c162-c168.
40. McCullough PA, Chinnaiyan KM: Annual progression of coronary calcification in trials of preventive therapies: a systematic review. Arch Intern Med 2009; 169: 2064-2070.
41. Guérin AP, Pannier B, Métivier F, Marchais SJ, London GM: Assessment and significance of arterial stiffness in patients with chronic kidney disease. Curr Opin Nephrol Hypertens 2008; 17: 635-641.
42. Bays HE: 'Sick fat', metabolic disease, and atherosclerosis. Am J Med 2009; 122(suppl): S26-S37.
43. Bagshaw SM, Cruz DN: Fluid overload as a biomarker of heart failure and acute kidney injury. Contrib Nephrol 2010; 164: 54-68.
44. Kimura G, Dohi Y, Fukuda M: Salt sensitivity and circadian rhythm of blood pressure: the keys to connect CKD with cardiovascular events. Hypertens Res 2010; 33: 515-520.
45. Ritz E, Koleganova N, Piecha G: Role of sodium intake in the progression of chronic kidney disease. J Ren Nutr 2009; 19: 61-62.
46. Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, McAlister F, Garg AX: Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 2006; 17: 2034-2047.
47. Stamler J: The INTERSALT Study: background, methods, findings, and implications. Am J Clin Nutr 1997; 65(suppl):626S- 642S.
48. He FJ, MacGregor GA: Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev 2004;CD004937.
49. Hooper L, Bartlett C, Davey SG, Ebrahim S: Advice to reduce dietary salt for prevention of cardiovascular disease. Cochrane Database Syst Rev 2004;CD003656.
50. Dracup K, Baker DW, Dunbar SB, Dacey RA, Brooks NH, Johnson JC, Oken C, Massie BM: Management of heart failure. II. Counseling, education, and lifestyle modifications. JAMA 1994; 272: 1442-1446.
51. Penne EL, Levin NW, Kotanko P: Improving volume status by comprehensive dietary and dialytic sodium management in chronic hemodialysis patients. Blood Purif 2010; 30: 71-78.
52. Stein G, Sperschneider H, Koppe S: Vitamin levels in chronic renal failure and need for supplementation. Blood Purif 1985; 3: 52-62.
53. Suliman ME, Lindholm B, Bárány P, Qureshi AR, Stenvinkel P: Homocysteine-lowering is not a primary target for cardiovascular disease prevention in chronic kidney disease patients. Semin Dial 2007; 20: 523-529.